Home/Filings/4/0001567619-23-000457
4//SEC Filing

Rienhoff Hugh JR 4

Accession 0001567619-23-000457

CIK 0001623715other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:27 PM ET

Size

10.1 KB

Accession

0001567619-23-000457

Insider Transaction Report

Form 4
Period: 2023-01-03
Rienhoff Hugh JR
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-03$2.52/sh+4,761$11,998494,287 total
  • Exercise/Conversion

    Common Stock

    2023-01-03$2.52/sh+7,415$18,686501,702 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-037,4150 total
    Exercise: $2.52From: 2021-01-01Exp: 2027-03-28Common Stock (7,415 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-034,7610 total
    Exercise: $2.52From: 2020-11-09Exp: 2026-11-08Common Stock (4,761 underlying)

Documents

1 file

Issuer

Imago BioSciences, Inc.

CIK 0001623715

Entity typeother

Related Parties

1
  • filerCIK 0001861072

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:27 PM ET
Size
10.1 KB